To help independent pharmacy owners better understand the fast-growing, uber-complex specialty pharmacy business, the National Community Pharmacists Association last month hosted a day-long forum, “Exploring the intersection of specialty medications, community pharmacy and patient care.”
How serious are Rite Aid’s leaders when they proclaim their determination to make the company a full-service, full-spectrum retail healthcare provider? Serious enough to buy RediClinic — which has operated walk-in healthcare clinics in roughly 30 H-E-B stores in Texas for much of the past decade — and serious enough to embark on an aggressive growth campaign that includes the clinic healthcare provider as a new Rite Aid subsidiary.
Rite Aid is back — and in a very big way. After years of toiling in the shadows of its fast-growing and better-capitalized rivals, the company has regained its footing and market momentum with a renewed vitality and a sharply defined focus on its mission as a community-driven health-and-wellness retailer.
More and more, the success of any healthcare delivery model in the United States will depend on the ability of all members of a patient-care team — physicians, pharmacists, hospital systems and health plan payers included — to collaborate effectively on a longterm plan of care that’s focused on successful outcomes and disease prevention.
Congress, Medicare and industry stakeholders should strike the right balance to cut out fraud in the Medicare Part D drug program while preserving patient access to critical medications, the National Community Pharmacists Association stated in comments submitted in conjunction with a House Energy and Commerce subcommittee hearing Tuesday on the topic.